Miconazole

Written for veterinarians and veterinary nurses.Are you a pet owner? The owner guides are here.

This page reprints a manufacturer label. Everything below in quotation marks is copied from Conzol ™ 1% (miconazole nitrate) Lotion & Spray, published by FDA and retrieved on 2026-09-16. Nothing has been added, reworded or left out of the sections shown. It is the manufacturer’s label, reproduced as published.

This page reprints the FDA label for Conzol ™ 1% (miconazole nitrate) Lotion & Spray by MWI, a miconazole product labelled for dogs and cats. The sections below are copied from that label without change, with the set id and the date it was retrieved from DailyMed. 1 other stored label carries the same active ingredient and is listed at the end.

The label

Product: Conzol ™ 1% (miconazole nitrate) Lotion & Spray. Manufacturer: MWI. FDA Structured Product Label set id ef1c9931-ce9d-4cf6-ac3f-7180d787e4dc. Label effective 2026-02-18. Retrieved 2026-09-16 from the DailyMed animal label release, and readable on DailyMed.

Indications

Conzol™ Lotion, 1% (miconzole nitrate) & Conzol™ Spray, 1% (miconzole nitrate) is indicated for the treatment of fungal infections in dogs and cats caused by Microsporum canis , Microsporum gypseum ​, and Trichophyton mentagrophytes .

Dosage and Administration

Accurate diagnosis of the infecting organism is essential. Identification should be made either by direct microscopic examination of a mounting of infected tissue in a solution of potassium hydroxide, or by culture on an appropriate medium. Lotion: Apply a light covering of Conzol ™ Lotion, 1% (miconazole nitrate) to affected areas, once daily, for 2 to 4 weeks. Application is best accomplished using a gauze pad or cotton swab. Spray: Spray affected areas from a distance of 2 to 4 inches to apply a light covering, once daily for 2 to 4 weeks. Do not allow pet to contact finished wood surfaces until pet is thoroughly dried. Medication must be continued until the infecting organism is completely eradicated as indicated by appropriate clinical or laboratory examination. If no improvement is noticed within 2 weeks, diagnosis should be re-evaluated. Difficult cases may require treatment for 6 weeks. General measures in regard to hygiene should be observed to control sources of infection or reinfection. Clipping of hair around and over the sites of infection should be done at the start of treatment and again as necessary. ACTIVE INGREDIENT : Miconazole Nitrate...........1.15% (equivalent to 1% miconazole base by weight)

Precautions

In the event of sensitization or irritation due to Conzol ™ Lotion, 1% (miconazole nitrate) & Conzol ™ Spray, 1% (miconazole nitrate), treatment should be discontinued. Avoid contact with eyes, since irritation may result. Wash hands thoroughly after administration to avoid spread of fungal infection.

Description

Conzol ™ Lotion, 1% (miconazole nitrate) & Conzol ™ Spray, 1% (miconazole nitrate) is a synthetic antifungal agent for use in dogs and cats. It contains: 1.15% miconzole nitrate (equivalent to 1% miconzole base by weight), polyethylene glycol 400, ethyl alcohol 55%.

Storage

Store at controlled room temperature between 15°-30°C (59°-86°F). Keep container tightly closed when not in use.

Other labels for this ingredient

These labels are also stored for the same active ingredient. They are not identical to the one reprinted above, and each is listed by product and set id rather than merged with it.

  • Miconazole nitrate 1%, Butler Animal health Supply, LLC dba Covetrus North America. Set id d7e2307f-d280-4a86-859d-99ecdfce3158.

FDA adverse event reports

The FDA Center for Veterinary Medicine publishes the adverse event reports it receives through openFDA. The counts below are the reports naming miconazole as an active ingredient for each species this label names, as returned on 2026-09-16, coded by the VeDDRA reaction term the reporter chose. Reactions are counted per report, so one report can appear under several terms.

These are counts, not rates. Reporting is voluntary, the number of animals treated is not known, and a widely used product accumulates reports for that reason alone. A report records that an event followed a dose; it does not establish that the product caused it. The counts say nothing about how one product compares with another.

Dogs: 2,316 reports

Reactions most often coded in dogs, 2,316 reports
VeDDRA reaction termReports
Loss of hearing553
Deafness298
Lack of efficacy - NOS248
Hearing affected158
Vomiting123
Lethargy (see also Central nervous system depression in 'Neurological')105
Impaired hearing103
Behavioural disorder NOS101
Hearing decreased92
Diarrhoea90
Other abnormal test result NOS77
Lethargy (see also Central nervous system depression in Neurological)65
Partial deafness65
Ear infection NOS62
Ear discharge61

Outcome as recorded by the reporter: Outcome Unknown 914; Recovered/Normal 556; Ongoing 551; Recovered with Sequela 147; Euthanized 46; Died 23.

Queries: reports, reactions, outcomes. Dataset: openFDA Animal and Veterinary Adverse Event Reports.

Cats: 141 reports

Reactions most often coded in cats, 141 reports
VeDDRA reaction termReports
Lack of efficacy - NOS20
Vomiting17
Hypersalivation11
Ataxia9
Death9
Diarrhoea9
Fever9
Lack of efficacy (bacteria) - NOS8
Anorexia7
Death by euthanasia7
Lack of efficacy (fungi) - NOS7
Lethargy (see also Central nervous system depression in 'Neurological')7
Not eating7
Weight loss6
Decreased appetite5

Outcome as recorded by the reporter: Outcome Unknown 46; Ongoing 30; Recovered/Normal 24; Died 11; Euthanized 5; Recovered with Sequela 2.

Queries: reports, reactions, outcomes. Dataset: openFDA Animal and Veterinary Adverse Event Reports.

Sources

Related

From Glarda

The note drafted from the consult, with the reference you just read sitting beside it in the shape your record already expects.

Glarda for practices